IP Library Granted Patent US 7,119,221
Granted Patent B2
US 7,119,221 · App. 10/743,287 · Granted Oct 10, 2006

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

Assignee: Esperion Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,119,221
App. No.
10/743,287
Granted
Oct 10, 2006
Kind
B2
Abstract

The present invention relates to novel cycloalkyl-hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, Syndrome X, thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

Claims (10)

1. A compound of structure:

or a pharmaceutically acceptable salt, hydrate, or enantiomer thereof.

2. A compound according to claim 1 wherein said compound has the structure:

or a pharmaceutically acceptable salt or hydrate thereof.

3. A compound according to claim 1 wherein said compound has the structure:

or a pharmaceutically acceptable salt or hydrate thereof.

4. A compound according to claim 1 wherein said compound has the structure:

or a pharmaceutically acceptable salt, hydrate, or enantiomer thereof.

5. A pharmaceutical composition comprising a compound of claim 1 , 2 , 3 , or 4 , and a pharmaceutically acceptable vehicle, excipient, or diluent.

6. A pharmaceutical composition comprising a compound of claim 1 , 2 , 3 , or 4 , and a pharmaceutically acceptable vehicle, excipient, or diluent which is administered in combination with a statin.

Assignments (2)
MERGER Recorded Oct 14, 2014
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033946/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2004
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 015456/0337 →
Continuity (2)
Provisional Application 6044179500 · Jan 23, 2003
Related Publication 20040209847A1 · Oct 21, 2004